Aldeyra Therapeutics
ALDX • NASDAQ
Aldeyra Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Todd C. Brady, with a market cap of $95.7M.
Market Cap$95.7M
Employees10.0
CEOTodd C. Brady
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Aldeyra Therapeutics FAQ
Common questions about Aldeyra Therapeutics
Aldeyra Therapeutics is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $47.0M.
Aldeyra Therapeutics has approximately 10 employees.